Skip to main content
DOW logo

DOW · Dow Inc.

Track DOW — free
$31.98 -0.72 (-2.20%) At close · Nov 5
Market Cap
$23.15B
Shares
723.88M
Volume · Nov 5 9.95M Avg daily vol (3M) 8.67M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$31.98 Open$33.08 Day$31.87–33.45 52W close$20.95–41.87 Avg vol 30d8.8M Short int30.3M · 4.2% of shares · 3.7d Short vol41% Last earningsJan 28, 2027 DataJan 2020–Nov 2026 Filing10-Q · Oct 23

Up next

Jan 28, 2027 Scheduled · in 12 wks

Latest documents

2026
Oct 23
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Dow reported third-quarter 2026 net sales of $11.3 billion, up 13 percent, and common-stockholder net income of $458 million, or $0.62 per share. Transform to Outperform delivered $450 million in Operating EBITDA improvement in the first nine months of 2026.

Revenue $11.27B ▲ 13.0% Net income $458M ▲ 638.7% Diluted EPS $0.62 ▲ 675.0%
Read from the MD&A section
Oct 22
Earnings call
Q3 2026 earnings call

Dow reported third-quarter net sales up 13% year over year and operating EBITDA more than $1.5 billion. It expects approximately $1.5 billion of fourth-quarter EBITDA and remains committed to approximately $1.3 billion in net benefits in 2027.

Oct 22
Current report 8-K
Financial results

Dow Inc. reported third-quarter 2026 net sales of $11.3 billion, up 13% year-over-year, GAAP net income of $525 million, operating EBIT of $887 million, GAAP EPS of $0.62, and operating cash flow of $1.8 billion; dividends totaled $253 million.

Jul 24
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $12.09B ▲ 19.7% Net income $721M Diluted EPS $0.99
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$42.61B
Trailing 12 months
Net income (TTM)
−$718.00M
Trailing 12 months
Revenue growth YoY
+13.0%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$13.38B
Latest balance sheet
Dividend yield
4.3%
Trailing 12 months
Shares change YoY
+2.0%
Year over year · more shares
Price change (1Y)
+44.8%
Trailing year
Short interest
4.2%
Latest settlement · 3.7 days to cover
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Poor Quant / Vol Moderate
Market backdrop VIX 28.2 · fear Equity put/call 0.44
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −2%
below
Price vs 50-day avg +6%
above
RSI (14) 53
neutral
MACD trend Positive
52-week position 53%
mid-range
Momentum
relative strength
Neutral
1-month return +12%
trailing
6-month return −17%
trailing
YTD return +37%
this year
Relative strength −17%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $30 › 200d $33 — 200d above 50d
Institutional flow Distributing
657 of 1,222 funds reported for Sep 30 · net -2.1M sh shares · +55 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
4.18% of shares out · ▼ -11.2% MoM · 3.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
1,222 holders — mid 3-yr range
Squeeze score 52
elevated · 0–100
Fundamentals
Poor
Revenue growth −7%
Y/Y
Gross margin 13%
contracting
EPS growth −336%
Y/Y
Buyback $931.0M
remaining
Balance sheet $14.3B
net debt
Quant / Vol
risk profile
Moderate
Volatility 42%
annualized · 1-yr
Max drawdown −35%
past year
ATR 3.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 3
Latest guidance · from the Earnings Call filed Oct 22, 2026
fourth quarter
EBITDA $1.5B
Lower sequential turnaround spending at least $100M
Sequential uplift from our self-help actions $100M
this year
Growth and productivity improvements $700M
second half of this year
Productivity improvements $150M
in the second half of the year
Release of working capital at least $500M
2027
Tailwind purely on self-help $1.3B
Previous outlook earlier release · from the Earnings Call filed Jul 23, 2026

Still-open targets the latest release did not restate under the same label.

Self-help benefits · this year at least $1.3B
Working capital release · second half of the year at least $500M
Benefits from self-help commitment · this year at least $1.3B
EBITDA uplift · second half $60M
Transform to outperform benefit · by the end of this year $700M
Operating rates · third quarter at least 90%
Prior guidance period ended · from the Earnings Call filed Jul 23, 2026
EBITDA · third quarter $1.7B
Guided vs delivered · last 3 settled
Total sales fourth quarter
guided $9.5B – $9.8B
$38.54B Beat +299.4%
Sales third quarter
guided $8.5B – $9B
$9.71B Beat +11.0%
Sales second quarter
guided $7.5B – $8.5B
$8.35B In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−2% Neutral
Price vs 50-day avg
+6% Bullish
RSI (14)
53 Neutral
MACD trend
Positive Bullish
52-week position
53% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $30 › 200d $33 — 200d above 50d
Institutional flow Distributing
657 of 1,222 funds reported for Sep 30 · net -2.1M sh shares · +55 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
4.18% of shares out · ▼ -11.2% MoM · 3.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
1,222 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $21 Now $32 · 53% Range high $42
vs 200-day avg -2% vs 50-day avg +6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Approximate dollar value of shares that may yet be purchased under the Company's publicly announ $931M Third quarter 2026 filing —
asset write-downs and write-offs 8M the second quarter of 2026 filing —
costs associated with exit and disposal activities 50M the second quarter of 2026 filing —
dividend to Dow Inc. $257M the three months ended September 30, 2026 filing —
Local price 14% third quarter of 2026 filing —
Local price & product mix 16% Three Months Ended Sep 30, 2026 filing —
Local price & product mix - Packaging & Specialty Plastics 17% three months ended September 30, 2026 filing —
pretax charges for severance and related benefit costs, related to Corporate 9M the third quarter of 2026 filing —
pretax restructuring charges 58M the second quarter of 2026 filing —
Product sales 98% the three months ended September 30, 2026 filing —
Segment Operating EBIT non-GAAP 915M Three months ended Sep 30, 2026 filing —
Local price & product mix - Performance Materials & Coatings 4% Three Months Ended Jun 30, 2026 filing —
Volume - Performance Materials & Coatings 6% Three Months Ended Jun 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
DOW
Dow Inc.
this stock
$23.15B +36.8% -7.0% — 4.2%
SHECF
Shin-Etsu Chemical Co., Ltd.
$66.38B +6.8% — — 0.1%
CE
Celanese Corp
$5.25B +13.2% -7.1% 20.2 5.3%
MEOH
Methanex Corp
$5.05B +64.8% — — 3.1%
SVYSF
Solvay S A
$2.80B -16.0% — — 0.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
1,214
% held
82.4%
Reported
657 of 1,222
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
652
View
Short & Settlement
Short Interest Falling
Shares short
30.3M
Days to cover
3.7d
Change
-3.8M sh
View
Short Volume
Short vol %
41%
As of
Nov 5, 2026
Short Total
View
Fails to Deliver
FTD shares
26
Value
$755
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
44.3%
Week of
Sep 28, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Alan Armstrong
Amount
$1.0K–$15.0K
Traded
Mar 27, 2026
View
Financials
Financials
Revenue (FY)
$40.0B
Net income (FY)
$4.6B
EPS diluted
$-3.70
View
Buybacks
Authorized
$3.0B
Remaining
$931.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 23, 2026
This year
23

Dow reported third-quarter 2026 net sales of $11.3 billion, up 13 percent, and common-stockholder net income of $458 million, or $0.62 per share. Transform to Outperform delivered $450 million in Operating EBITDA improvement in the first nine months of 2026.

View
Proposed Sales
Value
$135.3K
Shares
4.0K
Filed
Nov 2, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Jan 28, 2027
Last webcast
Oct 22, 2026
View
Investor Relations
Latest news
Dow reports third quarter 2026 re…
Published
Oct 22, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
DOW -4.9% +11.9% -17.5% -7.8% +36.8%
SPY -4.7% -5.3% -0.8% -3.0% +7.5%
vs SPY -0.2% +17.2% -16.6% -4.8% +29.3%

Capital returns

Latest dividend
$0.35 / share · ex Aug 31, 2026
Declared · upcoming
$0.35 / share · ex Nov 30, 2026
Cut 50%
Paid (TTM)
$1.40 / share · 4 payouts
Dividend yield (TTM, derived)
4.38%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$3.00B
Spent (derived)
$2.07B
Remaining
$931.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1751788 CUSIP 260557103 13F (30d) 630 filings 576 filers Visit website Investor relations